COVID-19 Testing Using Ovation LIMS

 Learn More

COVID-19 Testing Using Ovation LIMS

 

Pooling samples helps businesses and schools reopen safely

  • Saves time and precious resources
  • Increases capacity per well
  • Supports large volume and complex workflows
  • Automatic deconvolution for positive samples
  • Automatic Government Agency reporting
  • Works best for predominantly asymptomatic populations that use preventative actions like masks and social distancing

Rapid Implementation

The Ovation LIMS has out-of-the box support for COVID-19 testing and reporting. With the goal of unleashing the testing capacity of labs, ready to use capabilities include online order entry, standardized infectious disease workflow, automated interpretation following FDA and CDC guidelines, branded report template, and multimodal report delivery.

Start testing
 

COVID-19 Validation Guide

As the COVID-19 pandemic rages globally, access to testing has become incredibly important, not only for a patient’s own health and safety, but also for the health and safety of the community. Since we are all being affected by this, Ovation wants to enable labs to rapidly do something that makes a difference.

Ovation’s Head of Clinical Affairs, Dr. Pauline Gee, has consolidated information that we think might be helpful to labs seeking to bring up this testing. Please see our COVID-19 Validation Guide which lays out the exact steps a lab needs to take in order to develop a COVID-19 test and begin accepting patient samples.

Out-of-the-box Functionality

  • Online order entry
  • Standardized infectious disease workflow
  • Regulatory guided automated interpretation
  • Branded report template
  • Multimodal report delivery
Start Testing

Yes I want to do COVID-19 testing

  • This field is for validation purposes and should be left unchanged.

If you want to go straight to the source...

Food And Drug Administration

Policy for Diagnostics Testing in Laboratories Certified to Perform High Complexity Testing under CLIA prior to Emergency Use Authorization for Coronavirus Disease-2019 during the Public Health Emergency | Read More

FDA FAQs on Diagnostic Testing for SARS-CoV-2 | Read More

What If I Do Not Have…? | Read More

Virtual Town Halls, weekly on Wednesday afternoons from 3-4p EST, from March 25th through April 29th | Read More

Centers for Disease Control and Prevention

Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens from Persons for Coronavirus Disease 2019 (COVID-19) | Read More

Centers for Medicare & Medicaid Services

Medicare Administrative Contractor (MAC) COVID-19 Test Pricing Fact Sheet | Read More

Association for Molecular Pathology

Testing Resources for COVID-19 | Read More